# Novel Clinical Practice Assessments: Informational Statements by the Musculoskeletal Tumor Society

## TL;DR

This paper presents new assessments by the Musculoskeletal Tumor Society to improve collaboration and standardize best practices in treating rare musculoskeletal tumors.

## Contribution

The paper introduces systematic reviews of novel ideas and outlines needed research to standardize practices in musculoskeletal oncology.

## Key findings

- Musculoskeletal oncology lacks sufficient literature due to the rarity of the diseases.
- Systematic reviews and high-quality research are proposed to improve clinical practice and collaboration.
- Technological advances in the field require updated and standardized approaches.

## Abstract

Musculoskeletal oncology involves rare diseases. As a result, there is a paucity of literature to guide practitioners. Studies are often clinical experience, retrospective reviews, noncomparative studies, and involve small numbers of patients. However, technological advances consistently arise in this field. This article represents the Musculoskeletal Tumor Society efforts to improve multispecialty collaboration and research credibility. It involves brief systematic reviews of novel ideas and suggests high‐quality research needed to provide and standardize best practices within this field.